IGFBP2 was reported to play a key role in driving glioma cell growth via activation of the Akt pathway and to collaborate with K-Ras or platelet-derived growth factor β in the development and progression of glioma [32]. This evidence concerns the gene IGFBP2 and central nervous system cancer.